Bionano announces french publication of an effective method for analysis of multiple myeloma by ogm

San diego, april 08, 2025 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced a study published in the journal of molecular diagnostics that describes a method for analysis of multiple myeloma (mm) by optical genome mapping (ogm). mm is one of the most common blood cancers, or hematologic malignancies, and is understood to be a difficult sample to analyze using traditional cytogenetics. direct analysis of mm samples, by methods such as fish or ogm, can be problematic because it is challenging to isolate enough cells with a known mm marker (cd138) on their surface, so-called cd138-positive cells. in this paper, researchers at institute of medical genetics, lille university hospital, lille, france, have described a method for ogm that can overcome the hurdle of limited sample quantity and can cut in half the effective cd138-positive cell requirement for analysis by ogm.
BNGO Ratings Summary
BNGO Quant Ranking